NON-SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON-SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo shows promise in tough lung cancer
Disease control CompletedThis early-phase study tested whether adding an experimental drug called plinabulin to the standard immunotherapy nivolumab is safe and effective for people with advanced non-small cell lung cancer that has spread. The study enrolled 18 adults whose cancer had worsened after prio…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated May 01, 2026 18:27 UTC
-
New cocktail of cancer drugs tested for safety in advanced tumors
Disease control CompletedThis early-phase study tested the safety of combining multiple cancer drugs (niraparib, TSR-022, bevacizumab, chemotherapy, and TSR-042) in 60 people with advanced or metastatic solid tumors. The goal was to find safe doses for future studies. Participants had different types of …
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Radiation boost may help control advanced lung cancer longer
Disease control CompletedThis study tested adding a special type of radiation (SBRT) to standard targeted therapy pills for people with stage IV non-small cell lung cancer that has certain gene changes (EGFR, ALK, or ROS1). The goal was to see if this combination could delay the spread of cancer to new a…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC